c‐jun and multistage carcinogenesis: Association of overexpression of introduced c‐jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter‐induced transformation
- 1 May 1995
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 13 (1) , 27-36
- https://doi.org/10.1002/mc.2940130106
Abstract
Tumor promoters such as 12-O-tetradecanoylphorbol-13-acetate (TPA) and epidermal growth factor (EGF) induce neoplastic transformation, elevated c-jun protein expression, and activator protein-1 (AP-1)-dependent gene expression in JB6 mouse epidermal cells sensitive to tumor promoters (clone 415a P+ cells). In contrast, JB6 cells resistant to tumor promoter-induced transformation (clone 307b P- cells) exhibit a greatly reduced TPA or EGF inducible c-jun expression and AP-1 activity. We have recently shown that induced AP-1 is necessary for tumor promoter-induced transformation of P+ cells because introduction of a dominant negative c-jun mutant into P+ cells inhibits both AP-1 dependent transactivation and the transformation response to tumor promoter. The intent of the investigation presented here was to test the hypothesis that elevation of AP-1 activity is sufficient to cause progression to the P+ phenotype in P-cells or to the transformed phenotype in P+ cells. Clonally derived P+ and P- recipient cells transfected with a human c-jun expression construct and overexpressing c-jun protein were tested for progression by assaying for constitutive or inducible anchorage independent phenotype and nude-mouse tumorigenicity. Overexpression of c-jun did not produce progression in P- cells but did increase the probability of progression in P+ cells (two of five transfectant cell lines progressed to the tumor phenotype). In addition, c-jun overexpression did not increase AP-1 activity in any of the P-/c-jun transfectants or in the two of five P+/c-jun transfectants that acquired the transformed phenotype. The P+/c-jun transfectants that showed elevated AP-1 activity did not progress to the tumor phenotype, demonstrating that an increase in AP-1 activity is insufficient for this progression. Since P+-to-tumor phenotype progression occurred in cells overexpressing c-jun but not AP-1, we propose that P+-to-transformed phenotype progression is c-jun dependent and AP-1 independent.Keywords
This publication has 29 references indexed in Scilit:
- Jun family members are controlled by a calcium-regulated, cyclosporin A-sensitive signaling pathway in activated T lymphocytes.Genes & Development, 1993
- Differential c‐jun expression in response to tumor promoters in JB6 cells sensitive or resistant to neoplastic transformationMolecular Carcinogenesis, 1992
- 12‐O‐tetradecanoylphorbol‐13‐acetate—induced levels of ap‐1 proteins: a 46‐kda protein immunoprecipitated by anti‐fra‐1 and induced in promotion‐resistant but not promotion‐sensitive JB6 cellsMolecular Carcinogenesis, 1992
- Gene regulation and genetic susceptibility to neoplastic transformation: AP-1 and p80 expression in JB6 cells.Environmental Health Perspectives, 1991
- High‐level Expression of Human c‐jun Gene Causes Cellular Transformation of Chicken Embryo FibroblastsJapanese Journal of Cancer Research, 1991
- Obligatory wounding requirement for tumorigenesis in v-jun transgenic miceNature, 1990
- The phorbol ester receptor: a phospholipid-regulated protein kinaseBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1985
- Release of fibronectin is linked to tumor promotion: response of promotable and non-promotable clones of a mouse epidermal cell lineCarcinogenesis: Integrative Cancer Research, 1985
- Transformation and tumor promoter sensitive phosphoproteins in JB-6 mouse epidermal cells: one is also sensitive to heat stressCarcinogenesis: Integrative Cancer Research, 1984
- Tumour promoter induces anchorage independence irreversiblyNature, 1979